We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Wants to See More Elderly Patients in Anticancer Drug Studies
EMA Wants to See More Elderly Patients in Anticancer Drug Studies
January 16, 2013
The European Medicines Agency (EMA) has finalized a revised guideline on anticancer drug development, placing additional emphasis on the inclusion of elderly patients in clinical trials.